Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MARX Biotech Co's Other Operating Expense for the
six
months ended in Jun. 2026 was NT$0.0 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was NT$0.0 Mil.
MARX Biotech Co's annual Other Operating Expense
stayed the same
from Dec. 2023 (NT$0.0 Mil) to Dec. 2024 (NT$0.0 Mil) but then
declined
from Dec. 2024 (NT$0.0 Mil) to Dec. 2025 (NT$-0.0 Mil).
MARX Biotech Co Other Operating Expense Related Terms
MARX Biotech Co Other Operating Expense Historical Data
* Premium members only.
The historical data trend for MARX Biotech Co's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of NT$0.0 Mil mean?
MARX Biotech Co (ROCO:7731) has a Other Operating Expense of NT$0.0 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on MARX Biotech Co and its competitors.
Is MARX Biotech Co's Other Operating Expense too high?
MARX Biotech Co's current Other Operating Expense is NT$0.0 Mil. Overall, MARX Biotech Co has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MARX Biotech Co's Other Operating Expense compare to competitors?
MARX Biotech Co's Other Operating Expense of NT$0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Healthcare Providers & Services company?
A good Other Operating Expense depends on the Healthcare Providers & Services industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on MARX Biotech Co and its competitors. MARX Biotech Co's current Other Operating Expense is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MARX Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, MARX Biotech Co (ROCO:7731) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$5.13, compared to a current price of NT$4.41 — trading 14% below its estimated fair value. The current Other Operating Expense is NT$0.0 Mil. MARX Biotech Co's overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For MARX Biotech Co (ROCO:7731), the current Other Operating Expense is NT$0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MARX Biotech Co (ROCO:7731) Overvalued in 2026?
Based on GuruFocus' analysis, MARX Biotech Co stock appears to be undervalued.
The current stock price of NT$4.41 is trading 14% below its estimated GF Value™ of NT$5.13.
GuruFocus considers MARX Biotech Co to be Modestly Undervalued.
Key valuation signals for ROCO:7731:
Other Operating Expense: NT$0.0 Mil
GF Value™: NT$5.13 vs. price of NT$4.41 (14% below fair value)
No single metric tells the full story. See the ROCO:7731 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.
38GF Score
Get the complete analysis for ROCO:7731
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7731 has been successfully added to your 
